SEC Form 4 · accession 0001437749-19-001586
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Parker K Javid
Officer — Vice President
Period of report
Jan 30, 2019
Accepted (ET)
Jan 31, 2019 · 2:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Right to Buy Restricted Stock Unit (RSU)F1,F2 | — | Jan 30, 2019 | M | 3,631 | A | — | Jan 30, 2022 | Common Stock | 3,631 | 3,631 | D |
Explanation of responses
- F1The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis.
- F2Restricted Stock Units will be automatically settled in shares of common stock subject to achievement of the performance goals set forth in the Company's LTIP for 2021.